290 related articles for article (PubMed ID: 3899511)
21. Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.
Donaldson VH; Wagner CJ; Tsuei B; Kindness G; Bing DH; Harrison RA; Rosen FS
Blood; 1987 Apr; 69(4):1096-101. PubMed ID: 3493816
[TBL] [Abstract][Full Text] [Related]
22. Clinical problems in the C1-inhibitor deficient patient.
Agostoni A; Cicardi M; Cugno M; Storti E
Behring Inst Mitt; 1993 Dec; (93):306-12. PubMed ID: 8172581
[TBL] [Abstract][Full Text] [Related]
23. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
[TBL] [Abstract][Full Text] [Related]
24. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema.
Binkley KE; Davis A
J Allergy Clin Immunol; 2000 Sep; 106(3):546-50. PubMed ID: 10984376
[TBL] [Abstract][Full Text] [Related]
25. [C1 inhibitor deficiency. Heredity and acquired forms. Symptoms, diagnostic and therapeutic problems].
Obtułowicz K; Kapusta M; Obtułowicz A; Mazurkiewicz A
Przegl Lek; 2002; 59(6):438-41. PubMed ID: 12418282
[TBL] [Abstract][Full Text] [Related]
26. Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.
Gadek JE; Hosea SW; Gelfand JA; Frank MM
J Clin Invest; 1979 Jul; 64(1):280-6. PubMed ID: 376558
[TBL] [Abstract][Full Text] [Related]
27. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.
Wagenaar-Bos IG; Drouet C; Aygören-Pursun E; Bork K; Bucher C; Bygum A; Farkas H; Fust G; Gregorek H; Hack CE; Hickey A; Joller-Jemelka HI; Kapusta M; Kreuz W; Longhurst H; Lopez-Trascasa M; Madalinski K; Naskalski J; Nieuwenhuys E; Ponard D; Truedsson L; Varga L; Nielsen EW; Wagner E; Zingale L; Cicardi M; van Ham SM
J Immunol Methods; 2008 Sep; 338(1-2):14-20. PubMed ID: 18655790
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
29. Five novel mutations in the C1 inhibitor gene (C1NH) leading to a premature stop codon in patients with type I hereditary angioedema.
Freiberger T; Kolárová L; Mejstrík P; Vyskocilová M; Kuklínek P; Litzman J
Hum Mutat; 2002 Apr; 19(4):461. PubMed ID: 11933207
[TBL] [Abstract][Full Text] [Related]
30. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.
Donaldson VH; Rosen FS; Bing DH
Trans Assoc Am Physicians; 1977; 90():174-83. PubMed ID: 148134
[No Abstract] [Full Text] [Related]
31. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of a new C1 inhibitor mutant in a patient with hepatocellular carcinoma.
Monnier N; Ponard D; Duponchel C; Csopaki F; Bouillet L; Tosi M; Lunardi J; Drouet C
Mol Immunol; 2006 Jul; 43(14):2161-8. PubMed ID: 16529817
[TBL] [Abstract][Full Text] [Related]
33. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.
Alsenz J; Lambris JD; Bork K; Loos M
J Clin Invest; 1989 Jun; 83(6):1794-9. PubMed ID: 2723058
[TBL] [Abstract][Full Text] [Related]
34. Factor VIIa in patients with C1-inhibitor deficiency.
Nielsen EW; Morrissey J; Olsen JO; Osterud B
Thromb Haemost; 1995 Oct; 74(4):1103-6. PubMed ID: 8560420
[TBL] [Abstract][Full Text] [Related]
35. C1 inhibitor deficiency: hereditary and acquired forms.
Kaplan AP
J Investig Allergol Clin Immunol; 2001; 11(4):211-9. PubMed ID: 11908809
[TBL] [Abstract][Full Text] [Related]
36. Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema.
Cicardi M; Igarashi T; Kim MS; Frangi D; Agostoni A; Davis AE
J Clin Invest; 1987 Dec; 80(6):1640-3. PubMed ID: 2890659
[TBL] [Abstract][Full Text] [Related]
37. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
38. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
Gluszko P; Undas A; Amenta S; Szczeklik A; Schmaier AH
J Lab Clin Med; 1994 Feb; 123(2):232-40. PubMed ID: 8301199
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.
Kramer J; Katz Y; Rosen FS; Davis AE; Strunk RC
J Clin Invest; 1991 May; 87(5):1614-20. PubMed ID: 1902490
[TBL] [Abstract][Full Text] [Related]
40. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
